President of Pamela Y-F Yih, Inc. since 1993, Pamela Yih has joined The Triana Group as a founding member of its Life Sciences practice in 2010. As a consultant, she has been retained by small to leading pharmaceutical, biotech and diagnostic companies such as Aventis, Bristol Myers Squibb, Endo Pharmaceuticals, Lexicon Pharmaceuticals, Johnson and Johnson, Ocular Proteomics, Pfizer, Roche, and Vasogen. Earlier, she was a Director at Bristol-Myers Squibb, in charge of global Product Planning and Business Planning for the flagship ACE inhibitors $1.6 billion portfolio. Over her career, Pamela has worked in a broad range of therapeutic areas and successfully worked cross functionally with in-house and client teams.
Pamela started her career as an Assistant Professor, University of Nebraska College of Pharmacy and established innovative outpatient clinical pharmacy services at the Family Practice and Hematology/Oncology Clinics at the University of Nebraska Medical Center. She is a graduate of the Philadelphia College of Pharmacy and Science, where she received a Bachelor of Science in Pharmacy and a Doctorate of Pharmacy.[back]